SKYX News

Cloudbound™ Opens in New Rochelle, NY: A New Playspace for Families with Toddlers and Little Kids Ages 0-6

Skyhawk Therapeutics ogłasza dziewięciomiesięczne wyniki pośrednie badań klinicznych fazy 1 nad lekiem SKY-0515 stosowanym w leczeniu choroby Huntingtona USA - Polski APAC - English Korea - 한국어 USA - English USA - English USA - español

Skyhawk Therapeutics anuncia resultados de su ensayo clínico de SKY-0515 para la enfermedad de Huntington USA - español APAC - English Korea - 한국어 USA - English USA - English

SKYX Announces Closing of $25 Million in Funding via Offering of Common Stock at $2.50 per share from One Fundamental Institutional Investor

Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease USA - English APAC - English

Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease USA - English USA - English APAC - English

SKYX Announces Pricing of $25 Million Registered Direct Offering at $2.50 per share of Common Stock from One Fundamental Institutional Investor

SKYX Announces Launch at U.S Leading Retailer Lowes of its Ceiling Plug & Play SKYFAN & TURBO HEATER

Skysx Global Limited Advances Compliance-Oriented System and Risk Control Architecture

Skysx Global Limited Strengthens Global Operations and Multilingual Support Capabilities